Region:Middle East
Author(s):Shubham
Product Code:KRAD1035
Pages:96
Published On:November 2025
By Device Type:The market is segmented into various device types, including surgical devices, non-surgical devices, wearable devices, and others. Surgical devices, such as gastric bands and bypass devices, are gaining traction due to their effectiveness in weight loss. Non-surgical devices, including endoscopic suturing and intragastric balloons, are also popular for their minimally invasive nature. Wearable devices, like activity trackers and smart scales, are increasingly adopted for their role in promoting healthy lifestyles. Digital health platforms and mobile apps are emerging as significant players in the market, providing users with tools for weight management .
By Therapeutic Approach:The therapeutic approaches in the market include behavioral therapy, pharmacotherapy, nutritional counseling, and others. Behavioral therapy is gaining popularity as it addresses the psychological aspects of obesity, while pharmacotherapy, including GLP-1 receptor agonists and appetite suppressants, is increasingly utilized for its effectiveness in weight management. Nutritional counseling is essential for providing patients with tailored dietary plans. Other approaches, such as surgical interventions and digital therapeutics, are also contributing to the market's growth .
The Saudi Arabia Obesity Treatment Devices and Therapeutics Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic, Johnson & Johnson, Abbott Laboratories, Boston Scientific, Olympus Corporation, Stryker Corporation, Intuitive Surgical, Zimmer Biomet, B. Braun Melsungen AG, Hologic, Inc., Ethicon, Inc., Conmed Corporation, Cigna Corporation, Novo Nordisk, GSK, Allergan (AbbVie), Eisai Co., Ltd., Sanofi, Roche, Eli Lilly and Company, AstraZeneca, Takeda Pharmaceutical Company Limited, Al Borg Diagnostics, Dr. Sulaiman Al Habib Medical Group, Saudi German Hospitals Group, Dallah Health, Al Rajhi Medical Services, Al Faisal Medical Group, Al Nahdi Medical Company, Al Hayat Medical Group contribute to innovation, geographic expansion, and service delivery in this space.
The future of the obesity treatment devices and therapeutics market in Saudi Arabia appears promising, driven by increasing health awareness and technological advancements. The integration of artificial intelligence in treatment devices is expected to enhance patient outcomes significantly. Additionally, the expansion of telemedicine services will facilitate access to obesity treatments, particularly in remote areas. As the government continues to invest in public health initiatives, the market is likely to witness substantial growth, addressing the obesity epidemic effectively.
| Segment | Sub-Segments |
|---|---|
| By Device Type | Surgical Devices (e.g., gastric bands, gastric bypass devices) Non-Surgical Devices (e.g., endoscopic suturing, intragastric balloons) Wearable Devices (e.g., activity trackers, smart scales) Others (e.g., digital health platforms, mobile apps) |
| By Therapeutic Approach | Behavioral Therapy Pharmacotherapy (GLP-1 receptor agonists, lipase inhibitors, appetite suppressants) Nutritional Counseling Others (e.g., surgical interventions, digital therapeutics) |
| By End-User | Hospitals Clinics Home Care Settings Others (e.g., fitness centers, telehealth platforms) |
| By Age Group | Children Adults Elderly Others |
| By Gender | Male Female Others |
| By Region | Central Region Eastern Region Western Region Southern Region |
| By Distribution Channel | Online Sales Retail Pharmacies Hospitals Others (e.g., direct-to-consumer, specialty clinics) |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Healthcare Providers | 100 | Doctors, Nutritionists, Bariatric Surgeons |
| Patients Undergoing Treatment | 80 | Obesity Patients, Weight Management Program Participants |
| Device Manufacturers | 40 | Product Managers, R&D Managers |
| Healthcare Policy Makers | 40 | Health Ministry Officials, Public Health Experts |
| Insurance Providers | 40 | Claims Managers, Policy Underwriters |
The Saudi Arabia Obesity Treatment Devices and Therapeutics Market is valued at approximately USD 52 million, reflecting a significant growth trend driven by the rising prevalence of obesity and increased healthcare expenditure.
What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.
